Compile Data Set for Download or QSAR
Report error Found 82 Enz. Inhib. hit(s) with all data for entry = 13461
TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 50311018BDBM50311018(N-(cyanomethyl)-2-methyl-4-(2-(4-morpholinophenyla...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795205BDBM795205(2-methoxy-4-(2-(4-morpholinophenyl-amino)pyrimidin...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795205BDBM795205(2-methoxy-4-(2-(4-morpholinophenyl-amino)pyrimidin...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 50311017BDBM50311017(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyri...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795197BDBM795197(ethyl 4-(2-(4-morpholinophenyl-amino)pyrimidin-4-y...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795201BDBM795201(2-fluoro-5-(2-(4-morpholinophenyl-amino)pyrimidin-...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795211BDBM795211(4-(2-(4-morpholinophenyl-amino)pyrimidin-4-yl)-N-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795214BDBM795214(N-(cyanomethyl)-N-(4-(2-(4-morpholinophenyl-amino)...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 50311029BDBM50311029(N-(cyanomethyl)-4-(2-(4-thiomorpholinophenylamino)...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795208BDBM795208(2-chloro-4-(2-(4-morpholinophenyl-amino)pyrimidin-...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795208BDBM795208(2-chloro-4-(2-(4-morpholinophenyl-amino)pyrimidin-...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795209BDBM795209(N-(cyanomethyl)-4-(2-(3,4,5-trimethoxyphenyl-amino...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795209BDBM795209(N-(cyanomethyl)-4-(2-(3,4,5-trimethoxyphenyl-amino...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 50311019BDBM50311019(N-(cyanomethyl)-2-methoxy-4-(2-(4-morpholinophenyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 50311019BDBM50311019(N-(cyanomethyl)-2-methoxy-4-(2-(4-morpholinophenyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 50311032BDBM50311032(N-(cyanomethyl)-4-(2-(4-(4-methylpiperazin-1-yl)ph...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795222BDBM795222(N-(cyanomethyl)-4-(2-(4-(4-(pyrrolidin-1-yl)piperi...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795221BDBM795221(N-(cyanomethyl)-4-(5-methoxy-2-(4-morpholinophenyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795221BDBM795221(N-(cyanomethyl)-4-(5-methoxy-2-(4-morpholinophenyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795216BDBM795216(N-(cyanomethyl)-4-(2-(4-(4-hydroxypiperidin-1-yl)p...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795216BDBM795216(N-(cyanomethyl)-4-(2-(4-(4-hydroxypiperidin-1-yl)p...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795215BDBM795215(N-(2- (cyanomethylamino)- 2-oxoethyl)-4- (2-(4- mo...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795218BDBM795218(N-(cyanomethyl)-4-(2-(4-(4-(hydroxymethyl) piperi...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795217BDBM795217(N-(cyanomethyl)-4-(2-(4-(4-(hydroxymethyl) piperi...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795217BDBM795217(N-(cyanomethyl)-4-(2-(4-(4-(hydroxymethyl) piperi...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795228BDBM795228(N-(cyanomethyl)-4-(2-(4-(piperidin-4-yloxy)phenyla...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795227BDBM795227(N-(cyanomethyl)-4-(2-(4-(4-hydroxypiperidin-1-yl)p...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795227BDBM795227(N-(cyanomethyl)-4-(2-(4-(4-hydroxypiperidin-1-yl)p...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795230BDBM795230(N-(cyanomethyl)-4-(2-(3-(proproxymethyl) phenylam...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795229BDBM795229(4-(5-bromo-2-(4-morpholinophenyl-amino)pyrimidin-4...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795229BDBM795229(4-(5-bromo-2-(4-morpholinophenyl-amino)pyrimidin-4...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795224BDBM795224(4-(2-(4-(4-acetylpiperazin-1-yl)phenylamino) pyri...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795224BDBM795224(4-(2-(4-(4-acetylpiperazin-1-yl)phenylamino) pyri...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795223BDBM795223(4-(5-chloro-2-(4-morpholinophenyl-amino)pyrimidin-...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795226BDBM795226(N-(4-(2-(4-morpholinophenyl-amino)pyrimidin-4-yl)p...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795225BDBM795225(N-(cyanomethyl)-4-(5-methyl-2-(4-(4-(methylsulfona...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795225BDBM795225(N-(cyanomethyl)-4-(5-methyl-2-(4-(4-(methylsulfona...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 50311016BDBM50311016(2-cyano-N-(4-(2-(4-morpholinophenylamino)pyrimidin...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 50311016BDBM50311016(2-cyano-N-(4-(2-(4-morpholinophenylamino)pyrimidin...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795235BDBM795235(N-(4-(2-(3-cyano-4-morpholinophenyl-amino)pyrimidi...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795235BDBM795235(N-(4-(2-(3-cyano-4-morpholinophenyl-amino)pyrimidi...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 50311030BDBM50311030(N-Cyanomethyl-4-{2-[4-(1,1-dioxo-1lambda*6*-thiomo...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795237BDBM795237(N-(cyanomethyl)-4-(2-{[4-(1,1-dioxo-1lambda6,4-thi...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795232BDBM795232(4-(2-(3-allyloxymethyl)-4-morpholinophenyl amino)...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795231BDBM795231(2-cyano-N-(4-(2-(4-morpholinophenyl-amino)pyrimidi...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795234BDBM795234(N-(cyanomethyl)-N-(4-(2-(3-fluoro-4-morpholinophen...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795234BDBM795234(N-(cyanomethyl)-N-(4-(2-(3-fluoro-4-morpholinophen...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795233BDBM795233(N-(cyanomethyl)-4-(2-(4-(1-ethylpiperidin-4-yloxy)...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795240BDBM795240(N-(cyanomethyl)-4-(5-fluoro-2-(4-morpholinophenyl-...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 50311022BDBM50311022(N-(cyanomethyl)-4-(5-methyl-2-(4-morpholinophenyla...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2026
Entry Details
US Patent

Displayed 1 to 50 (of 82 total ) | Next | Last >>
Jump to: